title: Differential roles of cysteine residues in the cellular trafficking, dimerization, and function of the high-density lipoprotein receptor, SR-BI.
abstract: The scavenger receptor, class B, type I (SR-BI) binds high-density lipoprotein (HDL) and mediates selective delivery of cholesteryl esters (CEs) to the liver and steroidogenic cells of the adrenal glands and gonads. Although it is clear that the large extracellular domain (ECD) of SR-BI binds HDL, the role of ECD in the selective HDL-CE transport remains poorly understood. In this study, we used a combination of mutational and chemical approaches to systematically evaluate the contribution of cysteine residues, especially six cysteine residues of ECD, in SR-BI-mediated selective HDL-CE uptake, intracellular trafficking, and SR-BI dimerization. Pretreatment of SR-BI-overexpressing COS-7 cells with a disulfide (S-S) bond reducing agent, β-mercaptoethanol (100 mM) or dithiothreitol (DTT) (10 mM), modestly but significantly impaired SR-BI-mediated selective HDL-CE uptake. Treatment of SR-BI-overexpressing COS-7 cells with the optimal doses of membrane permeant alkyl methanethiosulfonate (MTS) reagents, positively charged MTSEA or neutral MMTS, that specifically react with the free sulfhydryl group of cysteine reduced the rate of SR-BI-mediated selective HDL-CE uptake, indicating that certain intracellular free cysteine residues may also be critically involved in the selective cholesterol transport process. In contrast, use of membrane impermeant MTS reagent, positively charged MTSET and negatively charged MTSES, showed no such effect. Next, the importance of eight cysteine residues in SR-BI expression, cell surface expression, dimer formation, and selective HDL-derived CE transport was evaluated. These cysteine residues were replaced either singly or in pairs with serine, and the mutant SR-BIs were expressed in either COS-7 or CHO cells. Four mutations, C280S, C321S, C323S, and C334S, of the ECD, either singly or in various pair combinations, resulted in significant decreases in SR-BI (HDL) binding activity, selective CE uptake, and trafficking to the cell surface. Surprisingly, we found that mutation of the two remaining cysteine residues, C251 and C384 of the ECD, had no effect on either SR-BI expression or function. Other cysteine mutations and substitutions were also without effect. Western blot data indicated that single and double mutations at C280, C321, C323, and C334 residues strongly favor dimer formation. However, they are rendered nonfunctional presumably because of mutation-induced formation of aberrant disulfide linkages resulting in inhibition of optimal HDL binding and, thus, selective HDL-CE uptake. These results provide novel insights into the functional role of four cysteine residues, C280, C321, C323, and C334, of the SR-BI ECD in SR-BI expression and trafficking to the cell surface, its dimerization, and associated selective CE transport function.
authors.affiliation: Geriatric Research, Education and Clinical Center, VA Palo Alto Health Care System, Palo Alto, California 94304, United States.
authors.forename: Jie
authors.initials: J
authors.lastname: Hu
authors.forename: Zhonghua
authors.initials: Z
authors.lastname: Zhang
authors.forename: Wen-Jun
authors.initials: WJ
authors.lastname: Shen
authors.forename: Ann
authors.initials: A
authors.lastname: Nomoto
authors.forename: Salman
authors.initials: S
authors.lastname: Azhar
mesh_terms: D000478:Alkylation; D019943:Amino Acid Substitution; D000818:Animals; D016466:CHO Cells; D019556:COS Cells; D002522:Chlorocebus aethiops; D002788:Cholesterol Esters / Q000378:metabolism; D006224:Cricetinae; D003412:Cricetulus; D003545:Cysteine / Q000737:chemistry*; D019281:Dimerization; D015536:Down-Regulation; D008075:Lipoproteins, HDL / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D016297:Mutagenesis, Site-Directed; D050505:Mutant Proteins / Q000737:chemistry / Q000378:metabolism; D010084:Oxidation-Reduction; D017434:Protein Structure, Tertiary; D021381:Protein Transport; D018110:Receptors, Lipoprotein / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D011994:Recombinant Proteins / Q000737:chemistry / Q000378:metabolism; D019163:Reducing Agents / Q000494:pharmacology; D051122:Scavenger Receptors, Class B / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*
chemical_list: D002788:Cholesterol Esters; C059714:HDL cholesteryl ester; D008075:Lipoproteins, HDL; D050505:Mutant Proteins; D018110:Receptors, Lipoprotein; D011994:Recombinant Proteins; D019163:Reducing Agents; C495124:SCARB1 protein, human; D051122:Scavenger Receptors, Class B; C031616:high density lipoprotein receptors; D003545:Cysteine
references.citation: J Biol Chem. 2005 Sep 23;280(38):32649-54
references.pmid: 16049011
references.citation: J Biol Chem. 2004 Jul 9;279(28):29832-40
references.pmid: 15123703
references.citation: Annu Rev Biophys Biomol Struct. 1992;21:323-48
references.pmid: 1326355
references.citation: J Biol Chem. 1989 May 15;264(14):8141-50
references.pmid: 2542267
references.citation: J Lipid Res. 1995 Jul;36(7):1602-17
references.pmid: 7595083
references.citation: J Biol Chem. 1951 Nov;193(1):265-75
references.pmid: 14907713
references.citation: Mol Pharmacol. 2002 Feb;61(2):303-11
references.pmid: 11809854
references.citation: J Biol Chem. 1996 Dec 27;271(52):33545-9
references.pmid: 8969220
references.citation: Trends Endocrinol Metab. 2003 Dec;14(10):467-72
references.pmid: 14643062
references.citation: J Lipid Res. 2002 Jun;43(6):861-71
references.pmid: 12032160
references.citation: Curr Opin Lipidol. 2009 Jun;20(3):236-41
references.pmid: 19421056
references.citation: Front Biosci. 2003 Sep 01;8:s998-1029
references.pmid: 12957864
references.citation: Biochem J. 1999 Aug 15;342 ( Pt 1):119-23
references.pmid: 10432308
references.citation: Endocrinology. 1998 Jun;139(6):2847-56
references.pmid: 9607793
references.citation: J Biol Chem. 1999 Jan 1;274(1):41-7
references.pmid: 9867808
references.citation: Neuropharmacology. 1996;35(7):797-804
references.pmid: 8938712
references.citation: J Biol Chem. 2002 Aug 2;277(31):27809-17
references.pmid: 12023954
references.citation: J Lipid Res. 1989 Oct;30(10):1551-60
references.pmid: 2614258
references.citation: J Lipid Res. 2009 Aug;50(8):1571-80
references.pmid: 19252221
references.citation: Nutr Metab (Lond). 2006 Dec 15;3:43
references.pmid: 17173681
references.citation: Annu Rev Cell Dev Biol. 2008;24:211-35
references.pmid: 18588487
references.citation: Curr Protein Pept Sci. 2009 Dec;10(6):614-25
references.pmid: 19538140
references.citation: Anal Biochem. 1978 Jun 15;87(1):206-10
references.pmid: 98070
references.citation: J Biol Chem. 2010 Feb 12;285(7):4732-40
references.pmid: 20018840
references.citation: J Clin Invest. 1996 Aug 15;98(4):984-95
references.pmid: 8770871
references.citation: Proc Natl Acad Sci U S A. 1983 Sep;80(17):5435-9
references.pmid: 6412229
references.citation: Biochim Biophys Acta. 2003 Feb 20;1631(1):42-50
references.pmid: 12573448
references.citation: Biochem J. 1991 Dec 1;280 ( Pt 2):359-65
references.pmid: 1747108
references.citation: J Clin Invest. 1984 Oct;74(4):1384-97
references.pmid: 6480831
references.citation: Methods Enzymol. 2002;343:137-56
references.pmid: 11665562
references.citation: J Biol Chem. 1998 Oct 9;273(41):26338-48
references.pmid: 9756864
references.citation: Biol Chem. 2003 Jan;384(1):117-23
references.pmid: 12674505
references.citation: Anal Biochem. 1977 Dec;83(2):346-56
references.pmid: 603028
references.citation: Biochemistry. 1994 Jun 7;33(22):6840-9
references.pmid: 8204619
references.citation: Nutr Metab (Lond). 2010 Jun 01;7:47
references.pmid: 20515451
references.citation: J Lipid Res. 2004 Mar;45(3):513-28
references.pmid: 14657200
references.citation: J Biol Chem. 2006 Dec 1;281(48):37227-36
references.pmid: 17015447
references.citation: J Lipid Res. 2001 Feb;42(2):170-80
references.pmid: 11181745
references.citation: Biochemistry. 1986 Sep 23;25(19):5595-601
references.pmid: 3778876
references.citation: J Biol Chem. 2008 Feb 22;283(8):4957-66
references.pmid: 18056267
references.citation: Sci Signal. 2009 May 26;2(72):re3
references.pmid: 19471024
references.citation: J Lipid Res. 1989 Nov;30(11):1799-810
references.pmid: 2614279
references.citation: J Biol Chem. 2010 Oct 1;285(40):30951-8
references.pmid: 20647307
references.citation: Biochemistry. 2011 Jul 19;50(28):6245-54
references.pmid: 21675794
references.citation: J Biol Chem. 2009 Mar 27;284(13):8918-29
references.pmid: 19158093
references.citation: J Biol Chem. 2004 Jun 11;279(24):24976-85
references.pmid: 15060063
references.citation: Endocr Rev. 2003 Jun;24(3):357-87
references.pmid: 12788804
references.citation: Rev Endocr Metab Disord. 2004 Dec;5(4):327-33
references.pmid: 15486465
references.citation: Science. 1996 Jan 26;271(5248):518-20
references.pmid: 8560269
references.citation: Neuron. 2003 Oct 30;40(3):515-25
references.pmid: 14642276
references.citation: Arteriosclerosis. 1988 May-Jun;8(3):298-309
references.pmid: 3370025
references.citation: Bioessays. 1988 Feb-Mar;8(2):57-63
references.pmid: 3282505
references.citation: Curr Med Chem. 2009;16(33):4419-44
references.pmid: 19835564
references.citation: Mol Cell Endocrinol. 2002 Sep 30;195(1-2):1-26
references.pmid: 12354669
references.citation: J Biol Chem. 1990 Nov 5;265(31):19100-11
references.pmid: 2229065
references.citation: J Lipid Res. 1998 Aug;39(8):1616-28
references.pmid: 9717722
references.citation: Adv Enzymol Relat Areas Mol Biol. 1990;63:69-172
references.pmid: 2407068
references.citation: EMBO J. 1993 May;12(5):2151-7
references.pmid: 8491203
references.citation: J Biol Chem. 1987 Feb 25;262(6):2443-50
references.pmid: 2434485
references.citation: J Biol Chem. 1996 Jul 5;271(27):16208-17
references.pmid: 8663101
references.citation: Biochemistry. 2005 Jun 21;44(24):8757-69
references.pmid: 15952782
references.citation: J Biol Chem. 2005 Apr 1;280(13):12330-8
references.pmid: 15664984
references.citation: Biochemistry. 2000 Apr 25;39(16):4649-57
references.pmid: 10769120
references.citation: J Neurosci. 2002 May 15;22(10):3873-80
references.pmid: 12019306
references.citation: Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6538-43
references.pmid: 10829064
references.citation: J Biol Chem. 2009 Nov 13;284(46):31953-61
references.pmid: 19773549
references.citation: Biochemistry. 2008 Oct 7;47(40):10576-86
references.pmid: 18778083
references.citation: J Lipid Res. 2000 Mar;41(3):343-56
references.pmid: 10706582
references.citation: J Clin Endocrinol Metab. 1998 Mar;83(3):983-91
references.pmid: 9506760
references.citation: J Biol Chem. 2007 Jul 13;282(28):20180-90
references.pmid: 17522058